In-vitro and companion diagnostic testing is critical to helping healthcare professionals identify therapies and monitor treatment response in patients. In-vitro Diagnostic (IVD) tests are used to determine quantitative or qualitative chemical (reagent) reactions to extracted or swabbed serum, plasma or blood samples and often fall under high-risk medical device classifications. Therapeutic drug monitoring is commonly used to continually monitor a patient’s treatment progress through frequent comparative diagnostic testing. Companion diagnostic tests are associated with particular pharmaceuticals,and help physicians confirm patient treatment eligibility. Companion diagnostics may also incorporate the use of software with artificial intelligence and machine learning capabilities to personalize medicine/care via predictive modeling based on prior sample reactions.
UL can assist in the documented safety precautions for Point of Care (POC) and rapid tests required by global regulatory entities for a variety of disease states including cancer, hepatitis/retrovirus, diabetes, and infectious diseases in addition to routine health screenings. We also work with clinical IVD kits and their corresponding high volume/throughput analyzers, instruments, and track systems which inherently pose several electrical, cybersecurity, and interoperability risks—none more acute than biologics in blood bank/transfusion environments used to screen blood donor units for transmissible diseases.
Historically, traditional IVD tests were administered in laboratories and other healthcare provider settings. Today, caregivers and public safety professionals may need to conduct COVID-19 and infectious disease screening remotely at airports, offices and other large-crowd facilities. The screeners need to collect proper swabs or samples swiftly and accurately to run rapid IVD tests, which makes clear instructions for use (IFU) and intuitive rapid or POC diagnostic product design more crucial than ever. Good usability can reduce the risks of errors of interpretation, essential for avoiding false results.
The European In-vitro Diagnostic Medical Devices Regulation 2017/46 (IVDR) specifies ergonomics and usability as part of the General Safety and Performance requirements. Our usability engineering experts can help manufacturers prepare the required usability data to demonstrate compliance with IVDR.
UL offers the following services to IVD manufacturers:
- CE Marking (via our Notified Body partner, PCBC)
- Auditing (ISO, MDSAP, NB)
- Batch verification
- Testing and certification
- Electrical, Fire and Mechanical safety testing
- Refrigeration testing for related laboratory equipment
- Electromagnetic compatibility
In addition to new devices, our team of tenured biomedical engineers and experts are able to support refurbishment of IVD immunoassay analyzers and sample dispensers. Our field service engineers can help with Quality Management System (QMS) compliance for contract manufacturers of IVD reagents, antibodies and test kits. Per quality requirements, we are also able to provide certification services to IVD manufacturers who do installation and preventative maintenance of IVD analyzer systems and software as well as resale transaction conformity and supply chain traceability.
We support these IVD NBOG codes for CE certification with our Notified Body partner, PCBC
- IVD 0101-AB-System
- IVD 0102 -Rhesus (C,c,D,E,e)
- IVD 0103 -Anti-Kell
- IVD 0201-HIV 1 and 2
- IVD 0202 -HTLV I and II
- IVD 0203 -Hepatitis B, C, D
- IVD 0302-Irregular anti-erythrocytic antibodies
- IVD 0303 -Congenital infections, rubella, toxoplasmosis
- IVD 0305 -Human infections: cytomegalovirus, chlamydia
- IVD 0307 -Tumoral marker: PSA
- IVD 0308 -Risk or trisomy 21 (incl software)
- IVD 0309 -Device for self-diagnosis for the measurement of blood sugar
- IVD 0401 -Clinical chemistry
- IVD 0405-Pregnancy and ovulation
UL 61010-1, IEC 61010-1
UL 61010-2-101, IEC 61010-2-101